Literature DB >> 15804267

Cerebrospinal fluid and serum neuron-specific enolase concentrations in a normal population.

M Casmiro1, S Maitan, F De Pasquale, V Cova, E Scarpa, L Vignatelli.   

Abstract

The aim of this study was to determine cerebrospinal fluid (CSF) and serum neuron-specific enolase (NSE) concentrations in a normal population and to analyse their relationship with sex and age. The sample was recruited among patients undergoing spinal anaesthesia, without neurological diseases. NSE was determined by means of immunometric assay. One hundred and eight patients (68 men) were recruited. CSF-NSE concentration was (mean +/- SD) 17.3 +/- 4.6 ng/ml (men 17.4 +/- 4.2, women 17.0 +/- 5.2, P = 0.62); serum concentration was 8.7 +/- 3.9 ng/ml (men 8.9 +/- 3.9, women 8.3 +/- 4.0, P = 0.06). The mean CSF/serum NSE ratio was 2.3 +/- 0.8 (men 2.2 +/- 0.8, women 2.4 +/- 0.9, P = 0.22). In both sexes, simple regression analysis showed not significantly increasing concentrations with advancing age for both CSF and serum NSE. Serum and CSF concentrations did not correlate in both sexes. In our study, CSF-NSE was twice the serum concentration; both were not influenced by sex or age. Serum and CSF-NSE values vary widely among different studies on normal populations because of different determination methods; therefore, each laboratory should obtain its own reference values. Finally, serum NSE should be used with caution as an indicator of CSF concentration as no correlation could be demonstrated between them in our study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804267     DOI: 10.1111/j.1468-1331.2004.01021.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  19 in total

1.  Role of Brain Biomarker in Predicting Clinical Outcome in Hypertensive Cerebrovascular Ischemic Stroke.

Authors:  Anuradha Bharosay; Vivek Vikram Bharosay; Kiran Saxena; Meena Varma
Journal:  Indian J Clin Biochem       Date:  2017-05-20

2.  Predictive value of neuron-specific enolase for prognosis in patients with moderate or severe traumatic brain injury: a systematic review and meta-analysis.

Authors:  Eric Mercier; Amélie Boutin; Michèle Shemilt; François Lauzier; Ryan Zarychanski; Dean A Fergusson; Lynne Moore; Lauralyn A McIntyre; Patrick Archambault; France Légaré; François Rousseau; François Lamontagne; Linda Nadeau; Alexis F Turgeon
Journal:  CMAJ Open       Date:  2016-07-22

3.  Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.

Authors:  Kayla M Pate; Regina M Murphy
Journal:  Isr J Chem       Date:  2017-01-18       Impact factor: 3.333

4.  Correlation of Brain Biomarker Neuron Specific Enolase (NSE) with Degree of Disability and Neurological Worsening in Cerebrovascular Stroke.

Authors:  Anuradha Bharosay; Vivek Vikram Bharosay; Meena Varma; Kiran Saxena; Ajoy Sodani; Ravi Saxena
Journal:  Indian J Clin Biochem       Date:  2011-11-08

5.  Secretoneurin as a marker for hypoxic brain injury after cardiopulmonary resuscitation.

Authors:  Julia Hasslacher; Georg Franz Lehner; Ulrich Harler; Ronny Beer; Hanno Ulmer; Rudolf Kirchmair; Reiner Fischer-Colbrie; Romuald Bellmann; Stefan Dunzendorfer; Michael Joannidis
Journal:  Intensive Care Med       Date:  2014-08-20       Impact factor: 17.440

6.  Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression.

Authors:  Laura Kranaster; Christoph Janke; Sonani Mindt; Michael Neumaier; Alexander Sartorius
Journal:  J Neural Transm (Vienna)       Date:  2014-05-07       Impact factor: 3.575

7.  Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury.

Authors:  Aslan Guzel; Uygur Er; Mehmet Tatli; Ufuk Aluclu; Umit Ozkan; Yucel Duzenli; Omer Satici; Ebru Guzel; Serdar Kemaloglu; Adnan Ceviz; Abdurrahman Kaplan
Journal:  Neurosurg Rev       Date:  2008-06-17       Impact factor: 3.042

8.  Axonal damage is remarkable in patients with acutely worsening symptoms of compression myelopathy: biomarkers in cerebrospinal fluid samples.

Authors:  Hiroshi Takahashi; Yasuchika Aoki; Arata Nakajima; Masato Sonobe; Fumiaki Terajima; Masahiko Saito; Takuya Miyamoto; Keita Koyama; Keiichiro Yamamoto; Takeo Furuya; Masao Koda; Seiji Ohtori; Masashi Yamazaki; Koichi Nakagawa
Journal:  Eur Spine J       Date:  2018-03-19       Impact factor: 3.134

Review 9.  Blood biomarkers for brain injury: What are we measuring?

Authors:  Keisuke Kawata; Charles Y Liu; Steven F Merkel; Servio H Ramirez; Ryan T Tierney; Dianne Langford
Journal:  Neurosci Biobehav Rev       Date:  2016-05-12       Impact factor: 8.989

10.  Molecular biomarkers in stroke diagnosis and prognosis.

Authors:  Matthew B Maas; Karen L Furie
Journal:  Biomark Med       Date:  2009-08-01       Impact factor: 2.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.